Our Services

Transplant Survival Rates

The Hillman Center for Pediatric Transplantation at Children’s Hospital of Pittsburgh of UPMC has performed more pediatric transplants than any other pediatric transplant center. Our transplant survival rates consistently beat the national average and are among the world’s best.

Transplant Survival Rates*
 

Liver Transplant Survival

1 Year 98% national average 95%
3 Years 97% national average 92%

 

Children’s Hospital of Pittsburgh has performed more than 1,500 pediatric liver transplants in children to date, making it the most active pediatric liver transplant center in the country.

Learn more about Children’s Hospital’s liver transplant program outcomes.



 

Intestine Transplant Survival

1 Year  100%  national average  87% 
3 Years 71% national average 71%

 

Children's Hospital has performed more pediatric intestinal transplants than any other center in the country. Patients of Children’s pediatric intestinal transplant program represent the world’s first and most successful series of small intestine transplants.

Learn more about Children’s Hospital’s intestine transplant program outcomes.



 

Heart Transplant Survival

1 Year 100% national average 92%
3 Years 100% national average 86%


Children's Hospital has performed more than 400 heart/lung transplants in children to date, including more than 300 pediatric heart transplants, making it one of the most active pediatric transplant centers in the world.

Learn more about Children’s Hospital’s heart transplant program outcomes.



 

Lung Transplant Survival

3 years 100% national average 66%


Our transplant team performs lung transplants for children suffering from lung disease including cystic fibrosis and pulmonary hypertension.

Learn more about Children’s Hospital’s lung transplant program outcomes.



 

Kidney Transplant Survival

1 Year 100% national average 99%
3 Years 100% national average 99%


Children's transplant team has performed kidney transplants on hundreds of children and teens, making it one of the most active pediatric kidney transplant centers in the world.

Learn more about Children’s Hospital’s kidney transplant program outcomes.



 

Blood and Bone Marrow Transplant Survival (2008-December 2013)

Outcome Measure Type Children's Hospital
100-Day Survival 1 All** 97%
One-Year Non-Relapsed Mortality2 All** 3% 
One-Year Overall Survival 3 All** 94%

 

Blood and Marrow Transplantation (BMT) is used to treat a number of cancers, blood diseases and immune disorders that were once considered incurable. The BMT program at Children's is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT).

** Includes auto-BMT, allo-related BMT, allo-unrelated and cord blood transplants.

1 Percentage of patients living one hundred or more days following the transplant procedure (This takes into account deaths due to transplant- and disease-related causes.)

2 Percentage of patients who died due to causes other than related to underlying disease

3 Percentage of patients living one or more years following the transplant procedure

* Sources: Internal data; Scientific Registry of Transplant Recipients (www.srtr.org) December 2014 release

 

Last Update
February 17, 2015
  • Increase/Decrease Text Size
  • Print This Page
Last Update
February 17, 2015
top